Epsom Salt
- Product NDC
- 50594-395
- Requested package NDC
- 50594-395-08
- 11-digit product format
- 505940395
- Labeler code
- 50594
- Product ID
- 50594-395_d0516ed9-eb5f-4e15-a8b6-b0b8a5b001e6
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Epsom Salt
- Dosage form
- GRANULE
- Route
- ORAL; TOPICAL
- Labeler
- Big Lots
- Application
- part334
- Marketing category
- OTC MONOGRAPH NOT FINAL
- Marketing start
- 2021-04-30
- Marketing end
- 0000-00-00
- Substance
- MAGNESIUM SULFATE HEPTAHYDRATE
- Active strength
- 1 g/g
- Pharmacologic classes
- Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 50594-395 | 50594-395-08 | D | Discontinued by firm | 2026-10-05 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Dashboard NDC Coverage#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50594-395-08 | 50594039508 | 3629 g in 1 POUCH (50594-395-08) | 3629 g | 2021-04-30 | 0000-00-00 | No | No | Current |